We've merged Palleos Healthcare to form a wide-reaching European CRO.
Find out more
ChinaBio® Partnering Forum, the largest and most productive life science partnering event in China, opens its doors on September 20–21, 2023 in Shanghai to give influential pharmaceutical industry stakeholders to explore new opportunities for connecting with new partners.
OCT Clinical is going to be a part of this event. Our team will be represented by Business Development Associate, Polina Nabieva. If you are interested in booking a meeting with us, feel free to reach out to Polina at pnabieva@oct-clinicaltrials.com
OCT Clinical is now operating under Palleos Healthcare brand name.
“The merger will undoubtedly create significant synergies, not just doubling but squaring the expertise of both companies”, Philip Räth, Ph.D., managing director at Palleos, said in the release.
“OCT Clinical is proud to join forces with palleos healthcare, as it has an excellent reputation in the industry it serves. Now we can offer tailored solutions to our clients to meet their diverse clinical research needs and accelerate the time of bringing their products to market”, Dmitry Sharov, CEO at OCT Clinical.